Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

High Rates of Herpes Simplex Virus Type 2 Infection in Homeless Women: Informing Public Health Strategies.

Kelly JD, Cohen J, Grimes B, Philip SS, Weiser SD, Riley ED.

J Womens Health (Larchmt). 2016 Aug;25(8):840-5. doi: 10.1089/jwh.2015.5579.

PMID:
27243474
2.

Parallel declines in HIV and hepatitis C virus prevalence, but not in herpes simplex virus type 2 infection: A 10-year, serial cross-sectional study in an inner-city emergency department.

Patel EU, Laeyendecker O, Hsieh YH, Rothman RE, Kelen GD, Quinn TC.

J Clin Virol. 2016 Jul;80:93-7. doi: 10.1016/j.jcv.2016.05.003.

PMID:
27232485
3.

Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection.

Skeate JG, Porras TB, Woodham AW, Jang JK, Taylor JR, Brand HE, Kelly TJ, Jung JU, Da Silva DM, Yuan W, Kast WM.

J Gen Virol. 2016 Feb;97(2):422-34. doi: 10.1099/jgv.0.000341.

4.

Prevalence and factors associated with herpes simplex virus type 2 infection in patients attending a Baltimore City emergency department.

Patel EU, Frank MA, Hsieh YH, Rothman RE, Baker AE, Kraus CK, Shahan J, Gaydos CA, Kelen GD, Quinn TC, Laeyendecker O.

PLoS One. 2014 Jul 18;9(7):e102422. doi: 10.1371/journal.pone.0102422.

5.

Sexual HIV/HSV-2 risk among drug users in New York City: an HIV testing and counseling intervention.

Pantin M, Leonard NR, Hagan H.

Subst Use Misuse. 2013 Apr;48(6):438-45. doi: 10.3109/10826084.2013.778279.

6.

Epidemiological impact of a genital herpes type 2 vaccine for young females.

Lou Y, Qesmi R, Wang Q, Steben M, Wu J, Heffernan JM.

PLoS One. 2012;7(10):e46027. doi: 10.1371/journal.pone.0046027.

7.

Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya.

Nyiro JU, Sanders EJ, Ngetsa C, Wale S, Awuondo K, Bukusi E, Price MA, Amornkul PN, Nokes DJ.

BMC Infect Dis. 2011 May 31;11:155. doi: 10.1186/1471-2334-11-155.

8.

Association between HSV1 seropositivity and obesity: data from the National Health and Nutritional Examination Survey, 2007-2008.

Karjala Z, Neal D, Rohrer J.

PLoS One. 2011 May 11;6(5):e19092. doi: 10.1371/journal.pone.0019092.

9.

Herpes simplex virus type 2 seropositivity and relationship status among U.S. adults age 20 to 49: a population-based analysis.

Bauer GR, Khobzi N, Coleman TA.

BMC Infect Dis. 2010 Dec 22;10:359. doi: 10.1186/1471-2334-10-359.

10.

Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.

Conrady CD, Halford WP, Carr DJ.

J Virol. 2011 Feb;85(4):1625-33. doi: 10.1128/JVI.01715-10.

11.

Herpes simplex virus type 2 associated with HIV infection among New York heterosexuals living in high-risk areas.

Hagan H, Jenness SM, Wendel T, Murrill CR, Neaigus A, Gelpi-Acosta C.

Int J STD AIDS. 2010 Aug;21(8):580-3. doi: 10.1258/ijsa.2010.010137.

12.

Group sex events amongst non-gay drug users: an understudied risk environment.

Friedman SR, Mateu-Gelabert P, Sandoval M.

Int J Drug Policy. 2011 Jan;22(1):1-8. doi: 10.1016/j.drugpo.2010.06.004. Review.

13.

Racial/ethnic disparities in undiagnosed infection with herpes simplex virus type 2.

Pouget ER, Kershaw TS, Blankenship KM, Ickovics JR, Niccolai LM.

Sex Transm Dis. 2010 Sep;37(9):538-43. doi: 10.1097/OLQ.0b013e3181d9042e.

14.

Seroepidemiology of viral hepatitis, HIV and herpes simplex type 2 in the household population aged 21-64 years in Puerto Rico.

Pérez CM, Marrero E, Meléndez M, Adrovet S, Colón H, Ortiz AP, Soto-Salgado M, Albizu C, Torres EA, Suárez E.

BMC Infect Dis. 2010 Mar 23;10:76. doi: 10.1186/1471-2334-10-76.

Supplemental Content

Support Center